Shu, T., Wu, X., Wei, C., Chen, C., Shen, C., Huang, Y., Zhou, J., Jiang, L., Yan, T., Shi, W., Ma, L., Yan, Y., Yu, T., Ji, N., Jiang, J., Xie, X., Zhu, P. (2025). ETS2 targets ZMYND11 to inhibit thyroid cancer progression via the mTOR signaling pathway. PLoS ONE. https://doi.org/10.1371/journal.pone.0328881